Contraceptives Market, By Type (Drugs (Oral Contraceptive Pills, Injectables, Topical), Devices (Male Condoms, Female Condoms, Diaphragms, Sponges, Vaginal Rings, Subdermal Implants, IUD)), and By Region (North America, Latin America, Europe, Asia Pacific

Contraceptives Market, By Type (Drugs (Oral Contraceptive Pills, Injectables, Topical), Devices (Male Condoms, Female Condoms, Diaphragms, Sponges, Vaginal Rings, Subdermal Implants, IUD)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Contraceptive drugs and devices that aid to control birth rate and unintended pregnancies are subject to unique regulatory challenges across different countries. For instance, contraceptive drugs and devices face reimbursement challenges in the U.S., while contraceptive pills face advertising restrictions in India. Owing to this, contraceptives preference greatly various across countries. Statistics revealed by the United Nations in 2015, highlight this trends, with a particular contraceptive accounting for over 50% share across 45 countries considered in the study. Sterilization is a dominant contraceptive method in regions such as Asia, North America, and Latin America as per the study.
Restraints of the Global Contraceptives Market
Major factors hampering the growth of the contraceptives market during the forecast period constitutes of side effects associated with drugs and devices, and low adoption of emergency contraceptives in emerging economies.
Key features of the study:
This report provides in-depth analysis of the global contraceptives market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global contraceptives market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Evofem Biosciences, Inc., Actavis Generics (Teva Pharmaceutical Industries Ltd.), Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Uniprix, Gavis Pharmaceuticals (Lupin Limited), Sandoz International GmbH, Aurobindo Pharma Limited, HRA Pharma, SA, Mankind Pharma, Merck & Co, Bayer HealthCare AG, Church & Dwight, Co. Inc., Allergan, Pfizer, Inc., Agile Therapeutics Inc., BioSante Pharmaceuticals Inc., Mayer Laboratories, Inc., and Pantarhei Bioscience B.V.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global contraceptives market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global Contraceptives Market, By Type:
Drugs
Oral Contraceptive Pills
Injectables
Topical
Devices
Male Condoms
Female Condoms
Diaphragms
Sponges
Vaginal Rings
Subdermal Implants
IUD
Global Contraceptives Market, By Geography:
North America
By Type
Drugs
Oral Contraceptive Pills
Injectables
Topical
Devices
Male Condoms
Female Condoms
Diaphragms
Sponges
Vaginal Rings
Subdermal Implants
IUD
By Country:
U.S.
Canada
Europe
By Type
Drugs
Oral Contraceptive Pills
Injectables
Topical
Devices
Male Condoms
Female Condoms
Diaphragms
Sponges
Vaginal Rings
Subdermal Implants
IUD
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Type
Drugs
Oral Contraceptive Pills
Injectables
Topical
Devices
Male Condoms
Female Condoms
Diaphragms
Sponges
Vaginal Rings
Subdermal Implants
IUD
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Type
Drugs
Oral Contraceptive Pills
Injectables
Topical
Devices
Male Condoms
Female Condoms
Diaphragms
Sponges
Vaginal Rings
Subdermal Implants
IUD
Middle East:
By Type
Drugs
Oral Contraceptive Pills
Injectables
Topical
Devices
Male Condoms
Female Condoms
Diaphragms
Sponges
Vaginal Rings
Subdermal Implants
IUD
By Country:
GCC
Israel
Rest of Middle East
Africa
By Type
Drugs
Oral Contraceptive Pills
Injectables
Topical
Devices
Male Condoms
Female Condoms
Diaphragms
Sponges
Vaginal Rings
Subdermal Implants
IUD
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Evofem Biosciences, Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Actavis Generics (Teva Pharmaceutical Industries Ltd.)
Sun Pharmaceutical Industries Ltd.
Perrigo Company plc
Uniprix
Gavis Pharmaceuticals (Lupin Limited)
Sandoz International GmbH
Aurobindo Pharma Limited
HRA Pharma
Mankind Pharma
Other Major Players
“*” marked represents similar segmentation in other categories in the respective section.